Description: Komipharm International Co., Ltd. manufactures and sells veterinary vaccines, veterinary pharmaceuticals and disinfectants, and bio-fertilizers internationally. It also develops anticancer drugs and pain-relieving agents, which include Kominox, an arsenic-based oral drug; and Panaphix, a non-narcotic cancer pain reliever, as well as provides clinical pathological experiment, test, and analysis services. The company was formerly known as Korea Microbiological Laboratories Co., Ltd. and changed its name to Komipharm International Co., Ltd. in September 2004. The company was founded in 1972 and is headquartered in Siheung, South Korea.
Home Page: www.komipharm.co.kr
17, Gyeongje-Ro
Siheung-Si,
South Korea
Phone:
82 3 1498 6104
Officers
| Name | Title |
|---|---|
| Mr. Seong-Cheol Moon | Chief Exec. Officer and Pres |
| Sang-Hyun Kim | Exec. Officer |
| Yi-Geun Park | Exec. Officer |
| Yong-Jin Yang | Chairperson, Chief Exec. Officer and Pres |
| Jung-Yeon Hwang | Sr. Managing Director |
| Kyung-Ho Yoo | Managing Director |
Exchange: KQ
Country: KR
Currency: Korean Won (₩)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0 |
| Price-to-Sales TTM: | 11.5197 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 153 |